Synergy of drugs and device for treating PAD: a concerted approach to improve patient outcomes

/Synergy of drugs and device for treating PAD: a concerted approach to improve patient outcomes
Loading Events
  • This event has passed.

COMPLIMENTARY REGISTRATION OPEN NOW>>

All times are in Eastern Time

Learning Objectives

  • List benefit of DCB and DES over BMS and PTA
  • Explain advantages and disadvantages of DCB over DES
  • Describe the concept of leave nothing behind
  • Outline global data on drug delivery for long lesions

Moderators

  • Subhash Banerjee, MD
  • Mehdi Shishehbor, DO, MPH, PhD

Faculty

  • Elissa Altin, MD, Yale New Haven Health
  • Herbert Aronow, MD, MPH, Lifespan
  • Manesh Patel, MD, Duke University School of Medicine

This activity has been approved for AMA PRA Category 1 Credit™.